
CAS 1256565-36-2
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 7 prodotti.
Ref: IN-DA01V5RH
25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta1mg153,00€5mg243,00€10mg363,00€PTC299
CAS:PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNAFormula:C25H20Cl2N2O3Purezza:99.72%Colore e forma:White SolidPeso molecolare:467.34Ref: TM-T12574
1mg111,00€5mg230,00€1mL*10mM (DMSO)236,00€10mg350,00€25mg590,00€50mg838,00€100mg1.144,00€PTC299
CAS:4-Chlorophenyl (S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indole-2-carboxylateFormula:C25H20Cl2N2O3Purezza:99+%Peso molecolare:467.344-CHLOROPHENYL (S)-6-CHLORO-1-(4-METHOXYPHENYL)-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOLE-2-CARBOXYLATE
CAS:Purezza:99+%Peso molecolare:467.3500061PTC299
CAS:PTC299 is a monoclonal antibody that binds to the CD20 protein on the surface of lymphocytes. This binding prevents CD20 from transmitting signals, leading to apoptotic cell death. PTC299 has been shown to be effective in treating chronic lymphocytic leukemia and eye disorders. The most common side effects are headache, nausea, vomiting, diarrhea, dizziness, and fatigue.
Formula:C25H20Cl2N2O3Purezza:Min. 95%Peso molecolare:467.3 g/mol






